Table 3.
Endocarditis | In-hospital Mortality | |
---|---|---|
Characteristic | OR (95% CI) | OR (95% CI) |
CA-MRSA | 2.73 (1.30, 5.71) | 2.93 (0.78, 10.96) |
Age | 0.98 (0.94, 1.03) | 1.08 (0.99, 1.17) |
Male Sex | 0.46 (0.22, 0.94) | 0.35 (0.10, 1.33) |
Receiving ART | 0.67 (0.31, 1.42) | * |
APACHE II ≥11 | 1.71 (0.85, 3.42) | ** |
CD4 <200 cells/mm3 | 2.01 (0.87, 4.62) | 0.47 (0.08, 2.91) |
Hepatitis C | 1.23 (0.60, 2.50) | 0.57 (0.16, 2.08) |
Hypertension | 0.92 (0.40, 2.12) | 0.91 (0.18, 4.57) |
Intravenous Drug Use | 1.79 (0.90, 3.59) | 1.58 (0.42, 5.87) |
End-stage Renal Disease | 1.23 (0.48, 3.12) | 0.56 (0.07, 4.68) |
Note: CA-MRSA: community-associated methicillin-resistant Staphylococcus aureus, ART: antiretroviral therapy, APACHE: Acute Physiology and Chronic Health Evaluation score
*Could not be calculated because no patients receiving ART died.
**Could not be calculated because no patients with APACHE <11 died.